213 / 1851
Study design
Cohorts
N Dose
(Route: IM)
Timing
Cohort 1 15
20 µg dHER2/AS15
D 0, 14, 28,
42
(70 & 98)
Cohort 2 15
100 µg dHER2/AS15 D 0, 14, 28, 42
(70 & 98)
Cohort 3 15
500 µg dHER2/AS15
D 0, 14, 28, 42
|
|
213 / 1851
Study design
Cohorts
N Dose
(Route: IM)
Timing
Cohort 1 15
20 µg dHER2/AS15
D 0, 14, 28,
42
(70 & 98)
Cohort 2 15
100 µg dHER2/AS15 D 0, 14, 28, 42
(70 & 98)
Cohort 3 15
500 µg dHER2/AS15
D 0, 14, 28, 42